References
- Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006;99(12):1293–1304. doi:https://doi.org/10.1161/01.RES.0000251742.71301.16
- Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost 2011;9(Suppl 1):44–55. doi:https://doi.org/10.1111/j.1538-7836
- Wang L, Ostberg O, Wihlborg AK, Brogren H, Jern S, Erlinge D. Quantification of ADP and ATP receptor expression in human platelets. J Thromb Hemost 2003;1(2):330–336. doi:https://doi.org/10.1046/j.1538-7836.2003.00070.x
- Nurden AT, Nurden P. Congenital platelet disorders and understanding of platelet function. Br J Haematol 2014;165(2):165–178. doi:https://doi.org/10.1111/bjh.12662
- Suzuki-Inoue K, Fuller GL, García A, Eble JA, Pöhlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006 Jan 15;107(2):542–549. doi:https://doi.org/10.1182/blood-2005-05-1994
- Hitchcock JR, Cook CN, Bobat S, Ross EA, Flores-Langarica A, Lowe KL, Khan M, Dominguez-Medina CC, Lax S, Carvalho-Gaspar M, et al. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest 2015 Dec;125(12):4429–4446. doi:https://doi.org/10.1172/JCI79070.
- Tamura S, Suzuki-Inoue K, Tsukiji N, Shirai T, Sasaki T, Osada M, Satoh K, Ozaki Y. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2. Blood 2016;127(13):1701–1710. doi:https://doi.org/10.1182/blood-2015-08-663708
- Gresele P, Harrison P, Gachet C, Hayward C, Kenny D, Mezzano D, Mumford A, Nugent D, Nurden A, Cattaneo M. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015;13(2):314–322. doi:https://doi.org/10.1111/jth.12792
- Yagmur E, Weiskirchen R, Schedel A, Bugert P. PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications. Thromb Haemost 2013;110(5):1083–1085. doi:https://doi.org/10.1160/TH13-02-0110
- Schedel A, Kaiser K, Uhlig S, Lorenz F, Sarin A, Starigk J, Hassmann D, Bieback K, Bugert P. Megakaryocytes and platelets express nicotinic acetylcholine receptors but nicotine does not affect megakaryopoiesis or platelet function. Platelets 2016;27(1):43–50. doi:https://doi.org/10.3109/09537104.2015.1026803
- Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics 1999;15(7–8):622–630. doi:https://doi.org/10.1093/bioinformatics/15.7.622
- Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ, Wiekowski MT, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001 Jun;107(12):1591–1598. doi:https://doi.org/10.1172/JCI12242.
- Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998 Dec 1;102(11):1994–2001. doi:https://doi.org/10.1172/JCI5116.
- Lecchi A, Razzari C, Paoletta S, Dupuis A, Nakamura L, Ohlmann P, Gachet C, Jacobson KA, Zieger B, Cattaneo M. Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis. Blood 2015 Feb 5;125(6):1006–1013. doi:https://doi.org/10.1182/blood-2013-07-517896.
- Mundell SJ, Rabbolini D, Gabrielli S, Chen Q, Aungraheeta R, Hutchinson JL, Kilo T, Mackay J, Ward CM, Stevenson W, et al. Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding. J Thromb Haemost 2018 Jan;16(1):44–53. doi:https://doi.org/10.1111/jth.13900.
- Mumford AD, Dawood BB, Daly ME, Murden SL, Williams MD, Protty MB, Spalton JC, Wheatley M, Mundell SJ, Watson SP. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis. Blood 2010 Jan 14;115(2):363–369. doi:https://doi.org/10.1182/blood-2009-08-236976.
- Nisar SP, Lordkipanidzé M, Jones ML, Dawood B, Murden S, Cunningham MR, Mumford AD, Wilde JT, Watson SP, Mundell SJ, et al. UK GAPP study group. A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction. Thromb Haemost 2014 May 5;111(5):923–932. doi:https://doi.org/10.1160/TH13-08-0672.
- Bugert P, Fischer L, Althaus K, Knöfler R, Bakchoul T. Platelet dysfunction caused by a novel thromboxane A2 receptor mutation and congenital thrombocytopenia in a case of mild bleeding. Platelets 2020;31(2):276–279. doi:https://doi.org/10.1080/09537104.2019.1652264
- Mundell SJ, Mumford A. TBXA2R gene variants associated with bleeding. Platelets 2018 Nov;29(7):739–742. doi:https://doi.org/10.1080/09537104.2018.1499888.
- Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010 Aug 6;285(32):24494–24507. doi:https://doi.org/10.1074/jbc.M110.130575.
- Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fässler R, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010 May 13;115(19):3997–4005. doi:https://doi.org/10.1182/blood-2009-04-216069.
- Gannon AM, Kinsella BT. Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes. J Lipid Res 2008;49:2590–2604. doi:https://doi.org/10.1194/jlr.M800256-JLR200
- Gannon AM, Turner EC, Reid HM, Kinsella BT. Regulated expression of the α isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1. J Mol Biol 2009;394:29–45. doi:https://doi.org/10.1016/j.jmb.2009.09.007
- Lenny N, Westendorf JJ, Hiebert SW. Transcriptional regulation during myelopoiesis. Mol Biol Rep 1997 Aug;24(3):157–168. Lengerke C, Daley GQ. Caudal genes in blood development and leukemia. Ann N Y Acad Sci. 2012 Aug;1266:47-54. doi:https://doi.org/10.1023/a:1006859700409.
- Tantin D. Oct transcription factors in development and stem cells: insights and mechanisms. Development 2013;140:2857–2866. doi:https://doi.org/10.1242/dev.095927
- Orkin SH, Shivdasani RA, Fujiwara Y, McDevitt MA. Transcription factor GATA-1 in megakaryocyte development. Stem Cells 1998;16(Suppl 2):79–83. doi:https://doi.org/10.1002/stem.5530160710